Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (25)

2023

  1. miR-203 drives breast cancer cell differentiation

    Breast Cancer Research, Vol. 25, Núm. 1

2022

  1. Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

    Cancers, Vol. 14, Núm. 10

2020

  1. Assessing autophagy in archived tissue or how to capture autophagic flux from a tissue snapshot

    Biology, Vol. 9, Núm. 3

  2. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

  3. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells

    Theranostics, Vol. 10, Núm. 11, pp. 5120-5136

  4. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

    Scientific Reports, Vol. 10, Núm. 1

  5. Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success

    World Journal of Urology, Vol. 38, Núm. 12, pp. 3121-3129

  6. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)

    Targeted Oncology, Vol. 15, Núm. 5, pp. 613-622

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

  3. S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

    Carcinogenesis, Vol. 40, Núm. 10, pp. 1260-1268

2018

  1. Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer

    Biochemical Pharmacology, Vol. 157, pp. 285-293

2016

  1. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

  2. Anticancer mechanisms of cannabinoids

    Current Oncology, Vol. 23, pp. S23-S32

  3. TRANSAUTOPHAGY: European network for multidisciplinary research and translation of autophagy knowledge

    Autophagy, Vol. 12, Núm. 3, pp. 614-617

2015

  1. Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications

    Neurotherapeutics, Vol. 12, Núm. 4, pp. 793-806

  2. Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts

    SpringerPlus, Vol. 4, Núm. 1

  3. Endocannabinoids and cancer

    Handbook of Experimental Pharmacology (Springer New York LLC), pp. 449-472

  4. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation

    Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144

  5. New inhibitors of angiogenesis with antitumor activity in vivo

    Journal of Medicinal Chemistry, Vol. 58, Núm. 9, pp. 3757-3766